Albumin Market Size

Albumin Market size was over USD 5.68 billion in 2024 and is poised to reach USD 12.51 billion by the end of 2037, growing at around 6.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of albumin is assessed at USD 5.97 billion.

The rising cases of liver diseases and infection have increased the demand for albumin, thus, driving market growth. The worldwide incidence of cirrhosis from autopsy results ranges from 4.5% to 9.5% of the population as a whole. It is estimated that in the next few years, more than fifty million adults worldwide will be afflicted with chronic liver disease. In the liver diseases, such as Ascites, albumin is used as a component for removing excess fluid from the abdomen. It helps prevent complications such as renal dysfunction and hypovolemia by maintaining plasma volume.

Furthermore, the rising discovery of new albumins is expected to augment the market growth. In April 2022, the article Impact of Serum Albumin Levels on COVID-19 Mortality implied that during admission if a COVID patient is injected with low levels of albumin serum. It can identify the patient who is at high risk of pneumonia and respiratory failure.